Pilot Verification of a Novel Approach to Remove Electrophoretic Interference of the Therapeutic Monoclonal Antibody Daratumumab.

Vandana BalodaMichael R ShurinSarah E Wheeler

Published in: The journal of applied laboratory medicine (2022)

SPIFE anti-Dara is a promising method to remove the interference of therapeutic monoclonal antibody daratumumab with SPE and IFE results in clinical laboratories and warrants further assessment.

Keyphrases

monoclonal antibody
multiple myeloma
ms ms
study protocol
randomized controlled trial
double blind